Elicio Therapeutics has secured $10 million in financing, ensuring operational support beyond anticipated milestones. With a focus on advancing clinical programs, Elicio aims to transform cancer treatment with its product candidates. The funding paves the way for future development initiatives and potential expansion into additional indications. Forward-looking statements underscore the company’s commitment to innovation and growth in the biotech sector. Elicio’s financial stability and strategic plans position it for continued success in bringing transformative therapies to market.
Read more from manilatimes.net
